Bruno Lagana'

Pubblicazioni

Titolo Pubblicato in Anno
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis BIOMEDICINES 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine VACCINES 2023
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies REUMATISMO 2023
Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: a prospective multicenter longitudinal study INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2022
Editorial: Chronic autoimmune arthritis, infections and vaccines FRONTIERS IN IMMUNOLOGY 2022
Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome. ARCHIVES OF CLINICAL AND MEDICAL CASE REPORTS 2022
Facial Transplantation: Nonimmune-Related Hyperacute Graft Failure-The Role of Perfusion Injury: A Case Report ANNALS OF PLASTIC SURGERY 2021
The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease MICROORGANISMS 2021
Inhibition of phosphodiesterase-4 in psoriatic arthritis and inflammatory bowel diseases INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Vitamin d signaling in gastro-rheumatology. From immuno-modulation to potential clinical applications INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
May bacterial infections trigger bullous pemphigoid? Case report and review of literature MICROORGANISMS 2021
Anti-COVID-19 vaccination in patients with autoimmune-autoinflammatory disorders and primary/secondary immunodeficiencies. The position of the task force on behalf of the italian immunological societies BIOMEDICINES 2021
Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice ANNALI DELL'ISTITUTO SUPERIORE DI SANITÀ 2021
Immunosuppressive Therapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients FRONTIERS IN IMMUNOLOGY 2021
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases THE JOURNAL OF RHEUMATOLOGY 2021
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later. The Era of Vaccines FRONTIERS IN IMMUNOLOGY 2021
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis. a real-life multicenter study EXPERT OPINION ON BIOLOGICAL THERAPY 2020
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2020
Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy DRUGS - REAL WORLD OUTCOMES 2020
Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in Italy MICROORGANISMS 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma